Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Annals of Hematology|February 20, 2019
Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemiaLoic Ysebaert, Marie Larcher, Gisele Compaci, et al.
BMC Cancer|August 16, 2019
Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemiaMartin Gauthier, Françoise Durrieu, Elodie Martin, et al.
Plos Medicine|July 22, 2024
New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modelingSarah Cadot, Chloe Audebert, Charlotte Dion, et al.
Histopathology|December 12, 2019
Exclusive B-cell phenotype of primary prostatic lymphomas: a potential role of chronic prostatitisSarah Péricart, Charlotte Syrykh, Nadia Amara, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 4, 2010
Hepatitis E virus excretion can be prolonged in patients with hematological malignanciesSuzanne Tavitian, Jean-Marie Péron, Anne Huynh, et al.
Cancers|October 14, 2022
Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin LymphomaClaire Lamaison, Juliette Ferrant, Pauline Gravelle, et al.
American Journal of Hematology|November 28, 2014
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)Anne Quinquenel, Christophe Willekens, Jehan Dupuis, et al.
Leukemia Research|October 9, 2025
Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemiaLin Wang, Murat Kurt, Tim Disher, et al.
Cancer Epidemiology|August 15, 2025
Impact of socioeconomic individual and ecological factors on extreme diagnosis-to-treatment interval in diffuse large B-Cell lymphoma in the French real-world cohort REALYSAChristelle Cantrelle, Aurélien Belot, Alain Monnereau, et al.
Blood|September 20, 2012
Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphomaWilfried Valleron, Loic Ysebaert, Laure Berquet, et al.
Pageof 7